Northrop Grumman is a clinical contract research organization, focusing on providing international standard clinical research outsourcing services for domestic and foreign customers, covering data management and statistical analysis, medical affairs and center management, as well as new drug evaluation and consulting services. Today Northrop Grumman made a public offering on the Shenzhen Stock Exchange.
This article is reprinted from: https://www.itjuzi.com/pre-ipo?comname=%E8%AF%BA%E6%80%9D%E6%A0%BC
This site is for inclusion only, and the copyright belongs to the original author.